Breast Cancer Cell Density: Imaging assay of the density- and context-dependence of small molecule perturbagen response in breast cancer cell lines. Dataset 1 of 3: Cell count and normalized growth rate inhibition values. - Dataset (ID:20256)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration | Small Mol Conc Unit | Replicate | Seeding Density | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value |
|---|---|---|---|---|---|---|---|---|---|---|
| BT-20 | 0 | uM | 3 | 156.25 | 49.48 | 154.00 | 112.09 | 1.3739 | 1.6179 | |
| Hs 578T | 0 | uM | 1 | 156.25 | 76.08 | 238.00 | 173.00 | 1.3757 | 1.6177 | |
| MDA-MB-231 | 0 | uM | 2 | 1250.00 | 570.38 | 1051.00 | 885.86 | 1.1864 | 1.6176 | |
| MCF7 | 0 | uM | 10 | 312.50 | 95.00 | 332.00 | 234.00 | 1.4188 | 1.6173 | |
| SK-BR-3 | Nilotinib | 0.1 | uM | 4 | 625.00 | 368.38 | 814.00 | 652.25 | 1.2480 | 1.6167 |
| BT-20 | Linsitinib | 0.1 | uM | 9 | 312.50 | 153.73 | 440.00 | 328.00 | 1.3415 | 1.6165 |
| SK-BR-3 | Linsitinib | 0.031623 | uM | 9 | 625.00 | 414.82 | 1005.00 | 785.00 | 1.2803 | 1.6160 |
| BT-20 | Etoposide | 0.1 | uM | 5 | 312.50 | 145.00 | 322.00 | 257.75 | 1.2493 | 1.6151 |
| SK-BR-3 | Linsitinib | 1 | uM | 9 | 625.00 | 414.82 | 1030.00 | 799.25 | 1.2887 | 1.6149 |
| BT-20 | 0 | uM | 4 | 156.25 | 44.67 | 80.00 | 68.00 | 1.1765 | 1.6148 | |
| MCF7 | 0 | uM | 1 | 625.00 | 173.50 | 334.00 | 278.25 | 1.2004 | 1.6147 | |
| MCF7 | 0 | uM | 1 | 156.25 | 31.46 | 106.00 | 75.55 | 1.4031 | 1.6147 | |
| BT-20 | 0 | uM | 9 | 312.50 | 153.73 | 350.00 | 278.25 | 1.2579 | 1.6147 | |
| Hs 578T | 0 | uM | 1 | 1250.00 | 718.46 | 895.00 | 841.82 | 1.0632 | 1.6146 | |
| SK-BR-3 | Erlotinib | 0.31623 | uM | 8 | 156.25 | 36.27 | 205.00 | 126.50 | 1.6206 | 1.6144 |
| MDA-MB-231 | 0 | uM | 2 | 625.00 | 269.08 | 1096.00 | 741.00 | 1.4791 | 1.6143 | |
| BT-20 | PLX-4720 | 3.1623 | uM | 5 | 625.00 | 303.96 | 1039.00 | 737.75 | 1.4083 | 1.6138 |
| SK-BR-3 | NVP-TAE684 | 0.01 | uM | 3 | 625.00 | 556.96 | 1375.00 | 1069.00 | 1.2862 | 1.6137 |
| MCF7 | 0 | uM | 1 | 625.00 | 173.50 | 301.00 | 258.18 | 1.1658 | 1.6136 | |
| BT-20 | Lapatinib | 0.031623 | uM | 9 | 312.50 | 153.73 | 410.00 | 312.00 | 1.3141 | 1.6134 |
| BT-20 | Lapatinib | 0.01 | uM | 9 | 312.50 | 153.73 | 410.00 | 312.00 | 1.3141 | 1.6134 |
| BT-20 | PLX-4720 | 0.0033113 | uM | 3 | 312.50 | 136.54 | 379.00 | 285.25 | 1.3287 | 1.6130 |
| BT-20 | Nilotinib | 1 | uM | 3 | 312.50 | 136.54 | 379.00 | 285.25 | 1.3287 | 1.6130 |
| SK-BR-3 | 0 | uM | 3 | 312.50 | 257.33 | 457.00 | 389.50 | 1.1733 | 1.6128 | |
| SK-BR-3 | Nilotinib | 0.031623 | uM | 4 | 1250.00 | 814.29 | 2058.00 | 1590.00 | 1.2943 | 1.6127 |